SciELO - Scientific Electronic Library Online

 
vol.39 número1Utilización de la flujometría Doppler en el manejo de la restricción del crecimiento pretérminoPapel del receptor 1 de transferrina en la captación del hierro y su relación con la deficiencia gestacional de hierro y la preeclampsia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista Cubana de Obstetricia y Ginecología

versión impresa ISSN 0138-600X

Resumen

VILLEGAS VALVERDE, Carlos Agustín  y  ARANGO PRADO, María del Carmen. Involvement of regulatory T cells in ovarian cancer. Rev Cubana Obstet Ginecol [online]. 2013, vol.39, n.1, pp.23-32. ISSN 0138-600X.

Regulatory T cells (Treg) lymphocytes are a subpopulation of lymphoid cells whose function is the regulation of the immune system. These cells have suppressor functions involved in the development and monitoring of malignancies. In ovarian cancer, an increase of Treg in tumor microenvironment and systemic circulation has been shown. The objective of this paper is to update the knowledge related to immune system involvement in ovarian cancer. Document review was used, through information search engines available on Hinari. The increase of Treg lymphocytes in the tumor microenvironment and systemic level is one of the mechanisms allowing the tumor to evade the immune response. This mechanism does not have the same impact in all tumors, however, ovarian cancer itself determines the existence of the disease progress. The Treg cells inhibit effector cells by mechanisms dependent on cell-cell contact and the release of cytokines such as interleukin-10 and beta transforming growth factor. The result of this increase is helping to trigger the tolerance mechanisms to the immune system action, thereby associating with poor prognostic parameters. There is scientific evidence on the involvement of Treg lymphocytes in ovarian cancer, which have allowed the understanding the impact they have on this disease clinical features and prognosis, offering attractive new therapeutic targets that will improve this disease course.

Palabras clave : ovarian cancer; regulatory T cells; immune response; immunotherapy.

        · resumen en Español     · texto en Español     · Español ( pdf )